Literature DB >> 338223

Serum-associated inhibition of leukotaxis in humans with cancer.

E G Maderazo, T F Anton, P A Ward.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 338223     DOI： 10.1016/0090-1229(78)90068-5

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN： 0090-1229


× No keyword cloud information.
  25 in total

1.  In vitro and in vivo production of chemotactic inhibitors by tumor cells.

Authors:  M C Cohen; J P Brozna; P A Ward
Journal:  Am J Pathol       Date:  1979-03       Impact factor: 4.307

2.  Serum associated leucocyte locomotion inhibition and leucocyte motility in malignant melanoma: effect of BCG treatment.

Authors:  C Zielinski; H Pehamberger; A T Endler; W Knapp
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

3.  Identification of an IgA inhibitor of neutrophil chemotaxis and its membrane target for the metabolic burst.

Authors:  J N Moy; R D Nelson; K L Richards; M K Hostetter
Journal:  Immunology       Date:  1990-02       Impact factor: 7.397

4.  Impairment of neutrophil chemotaxis by serum from patients with chronic lymphoproliferative disease.

Authors:  U Jayaswal; S Roper; S Roath
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

5.  Abnormal monocyte chemotaxis in patients with chronic purulent rhinosinusitis: an effect of retroviral p15E-related factors in serum.

Authors:  E M van de Plassche-Boers; M Tas; M de Haan-Meulman; M Kleingeld; H A Drexhage
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

6.  Defects of serum chemoattraction and polymorphonuclear leucocyte movement in patients with primary hepatocellular carcinoma.

Authors:  A G Yousif-Kadaru; R J Wyke; I A Rajkovic; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1982-08       Impact factor: 4.330

7.  Decreased T lymphocyte migration in patients with malignancy mediated by a suppressor cell population.

Authors:  D G Hesse; D J Cole; D E Van Epps; R C Williams
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

Review 8.  Recovery of uncommon bacteria from blood: association with neoplastic disease.

Authors:  J L Beebe; E W Koneman
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Serum stimulatory activity and polymorphonuclear leucocyte movement in patients with fulminant hepatic failure.

Authors:  R J Wyke; A G Yousif-Kadaru; I A Rajkovic; A L Eddleston; R Williams
Journal:  Clin Exp Immunol       Date:  1982-11       Impact factor: 4.330

10.  Serum inhibitory effect on myeloperoxidase in human cancer.

Authors:  B Senelar; R Michel; J Tournamille; H Vannereau; M J Escola; J Taib; A Craste de Paulet
Journal:  Br J Exp Pathol       Date:  1982-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.